Table 3 Cardiovascular and neurally-mediated diagnostic tests
Total population (n = 107) | Possible Epilepsy (n = 63) | Drug-resistant Epilepsy (n = 44) | |
|---|---|---|---|
Abnormal ECGa, n (%) | 9 (8.4) | 6 (9.5) | 3 (6.8) |
Orthostatic Hypotension, n (%) | 33 (30.8) | 17 (27.0) | 16 (36.4) |
Head-up Tilt testing | |||
Performed, n (%) | 92 (86.0) | 55 (87.3) | 37 (84.1) |
Diagnostic, n (%) | 52 (48.6) | 35 (55.6) | 17 (38.6) |
Myoclonic jerks, n (%) | 18 (16.8) | 16 (25.4) | 2 (4.5) |
Carotid Sinus Massage | |||
Performed, n (%) | 104 (97.2) | 60 (95.2) | 44 (100.0) |
Diagnostic, n (%) | 7 (6.5) | 5 (7.9) | 2 (4.5) |
Echocardiography performed b, n (%) | 43 (40.2) | 27 (42.9) | 16 (36.4) |
24 h Holter monitoring performedc, n (%) | 43 (40.2) | 20 (31.7) | 23 (52.3) |
Exercise test performed, n (%) | 13 (12.1) | 10 (15.9) | 3 (6.8) |
Electrophysiological study performed, n (%) | 3 (2.8) | 2 (3.2) | 1 (2.3) |
ILR implanted d, n (%) | 13 (12.1) | 6 (9.5) | 7 (15.9) |